Event Abstract Back to Event Absorbable polymer degradation responding to artificial plaque composition Aleer Yol1 and Ji Guo1 1 U.S. Food and Drug Adminstration, Center for Devices and Radiological Health, United States Introduction: New generation of drug-eluting stents (DES) are composed of absorbable polymers like Poly(lactic-co-glycolic acid) (PLGA). To assess the safety and efficacy of DES, it is critical to know the degradation behavior of these polymers upon stent application. It is well established that the composition of atherosclerotic vessels can vary dramatically with patients’ age and gender [1],[2]. These physical and chemical differences in the local vascular environment may impact the degradation pathway and rate. If the effect is significant, treatment with the same device, such as a DES using biodegradable polymers or a completely absorbable stents, may lead to different clinical outcomes. Although there is evidence that local environment impacts the degradation pathway, the extent of the impact has not been quantified. Our study used artificial plaques to assess potential differences in degradation of absorbable polymers with respect to known physiological differences in the composition and chemistry of atherosclerotic plaque. Materials and Methods: Poly(lactic-co-glycolic acid)with L/G 50:50, (PLGA 50) (Durect Corp), Gelatin (from bovine skin, type B; Sigma-Aldrich), Glutaraldehyde (GTA) (Fisher Scientific, 25%), Phospholipid (Avanti Polar Lipids), Cholesterol (Sigma-Aldrich), cholesteryl palmitate (Sigma-Aldrich), cholesteryl oleate (Alfa Aesar), cholesteryl linoleate (Sigma-Aldrich), Water (Fisher Scientific) and Acetonitrile (Sigma-Aldrich) were used as received. PLGA 50 films were prepared by casting 30% PLGA solution in dichloromethane at the bottom of 20 mL scintillation vials. Artificial plaque was prepared according to our previous studies [3] and was mounted on top of each PLGA film. PLGA films were degraded in the presence of artificial plaque at 37 °C and sampled weekly for analysis. PLGA degradants extracted from the artificial plaques were analyzed with an electrospray ionization (ESI) linear ion trap mass spectrometer (MS) (Thermo). Molecular weights of residual polymer films were monitored by gel permeation chromatography (GPC) (Waters). Results and Discussion: PLGA 50 films were degraded in contact with three different artificial plaque, no lipids, 0.022% lipids (w/w), and 0.034% lipids (w/w), respectively. There is no observable difference in degradation rate of PLGA films in the presence of three artificial plaques, as the silimiar molecular weights are recorded for these films at same timepoints. Though it is not feasible to measure the mass loss directly, MS analysis revealed that mass loss occurred earlier for PLGA films degraded in the presence of an artificial plaque with the highest lipid content (0.034%). We also found the major degradation products varied when of PLGA films degraded in artificial plaques with different compositions, as shown in Figure 1. At week five of degradation, the degradants with long glycolic units significantly diminished when PLGA films were degraded in artificial plaques with large amounts of lipids (Figure 1c). Conclusion: We assessed the impacts of artificial plaque composition on the degradation of PLGA 50. It is clear that plaque chemistry and composition influence the degradation behavior of absorbable polymers, such as mass loss and the amount and type of degradation products. This research will strongly facilitate the evaluation of the safety and efficacy of DES containing absorbable polymers. FDA Office of Women’s Health